ARTICLE | Company News
CombinatoRx, Accelerate Brain Cancer Cure, Duke University deal
October 4, 2004 7:00 AM UTC
CombinatoRx will use its combination high throughput screening (cHTS) platform to identify combination products that hit multiple targets relevant to treating glioblastoma multiforme (GBM). The univer...